Carfilzomib, pomalidomide, and dexamethasone for relapsed or refractory myeloma
Autor: | Shah, Jatin J. *, Stadtmauer, Edward A., Abonour, Rafat, Cohen, Adam D., Bensinger, William I., Gasparetto, Cristina, Kaufman, Jonathan L., Lentzsch, Suzanne, Vogl, Dan T., Gomes, Christina L., Pascucci, Natalia, Smith, David D., Orlowski, Robert Z., Durie, BrianG.M. |
---|---|
Zdroj: | In Blood 12 November 2015 126(20):2284-2290 |
Databáze: | ScienceDirect |
Externí odkaz: |